BASF is navigating one of the most significant strategic shifts in its recent history. As plans to list its multi-billion-euro agricultural solutions business gain momentum, investor sentiment is tempered by currency pressures and a disappointing earnings forecast.
Financial Resilience and Shareholder Returns
Despite facing operational challenges, the chemical giant maintains considerable financial strength. A significant liquidity event is on the horizon with the pending sale of its coatings business to private equity firm Carlyle. This transaction is expected to inject approximately 5.8 billion euros, before taxes, into BASF’s coffers during the second quarter.
A portion of this capital is already being returned to shareholders through an ongoing share buyback initiative, which runs until 2028. The company had repurchased its own shares worth 789 million euros by early March. This financial buffer provides the conglomerate with flexibility as it executes its complex restructuring.
The Road to a Landmark Listing
The core of BASF’s transformation is the legal separation and planned public listing of its Agricultural Solutions division. This unit, which generated nearly ten billion euros in sales in 2024, is being prepared for an Initial Public Offering (IPO) with its own independent IT infrastructure. BASF intends to retain a majority stake, ensuring it continues to benefit from the segment’s future earnings.
Final approval for this move is slated for the Annual General Meeting on April 30, 2026, where it will be presented as a contribution in kind against new business shares. Should shareholders endorse the plan, Dr. Livio Tedeschi is set to assume the role of CEO for the newly independent company starting May 1, 2026.
Should investors sell immediately? Or is it worth buying BASF?
Operational Pressures and Strategic Response
A challenging market environment complicates the strategic overhaul. Management is contending with the dual headwinds of higher US tariffs and a weak US dollar, which are negatively impacting operational performance. Currency effects alone are projected to reduce earnings by up to 200 million euros in the first quarter.
In response to persistently weak demand from key European industries like construction and automotive, the company has intensified its existing cost-saving program. The goal is now to reduce annual costs by 2.3 billion euros by the end of 2026.
This backdrop informs a cautious outlook for the full year 2026. BASF’s targeted EBITDA midpoint of 6.6 billion euros falls notably short of market expectations, which hover around 7.0 billion euros.
Key Dates for Investors
The coming weeks present critical milestones for shareholders:
- April 30, 2026: Annual General Meeting in Mannheim and release of Q1 financial results.
- May 1, 2026: New management board for Agricultural Solutions takes office.
- May 4, 2026: Ex-dividend date for the 2.25 euro per share payout.
The April 30th meeting will be a focal point, where strategic and operational narratives converge. The quarterly report will offer concrete evidence of whether the company’s aggressive cost-cutting measures and price increases are sufficient to offset the substantial currency-related pressures on its balance sheet.
Ad
BASF Stock: Buy or Sell?! New BASF Analysis from April 4 delivers the answer:
The latest BASF figures speak for themselves: Urgent action needed for BASF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 4.
BASF: Buy or sell? Read more here...
